Estelle Balducci

Paris, 75015, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Oncogenic PIK3CA mutations shape an immunoregulatory microenvironment in mosaic overgrowth disorders.

Oncogenic PIK3CA mutations shape an immunoregulatory microenvironment in mosaic overgrowth disorders.

Journal: PNAS nexus
Published: January 23, 2026

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

Journal: Hematological oncology
Published: September 24, 2025

TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemia.

TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemia.

Journal: HemaSphere
Published: August 08, 2025

PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 24, 2025

LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.

LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.

Journal: Blood
Published: June 02, 2025

Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes.

Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes.

Journal: HemaSphere
Published: February 26, 2025

Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).

Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).

Journal: Leukemia
Published: January 28, 2025

First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrum.

First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrum.

Journal: European journal of human genetics : EJHG
Published: January 22, 2025

Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformations.

Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformations.

Journal: Brain communications
Published: November 04, 2024

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Journal: Blood
Published: September 09, 2024

Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation.

Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation.

Journal: The New England journal of medicine
Published: July 17, 2024

Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.

Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.

Journal: European journal of haematology
Published: July 16, 2024
Showing 1-12 of 38

Last Updated: 09/26/2026